Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Owens & Minor (NYSE:OMI) Rating was Increased by Professional Analysts at Robert W. Baird from Underperform to Neutral. The Target Price per Share is to $28.0

Robert Baird Analyst Rating Change Owens & Minor NYSE:OMI

Owens & Minor (NYSE:OMI) Rating Upped

Trading of Owens & Minor (NYSE:OMI)’s shares is going to be interesting today, as Robert W. Baird raised the stock from a Underperform to a Neutral. Along the rating upgrade, Robert W. Baird analysts gave a target price of $28.0 or -1.16 % more.

The firm’s rating upgrade is welcomed by equity trades, as NYSE:OMI is currently trading 1.40% higher at $28.33 as of 6:11 PM New York time. Owens & Minor shares have [From2] 0% over the past 200 days, while the Standard & Poor’s 500 index has increased 6.00% during the same time period.

According to data compiled by Thomson Reuters, Owens & Minor (NYSE:OMI)’s stock is covered by 7 equity analysts across the Street, with 2 analysts giving it a Sell rating, 0 a Buy rating, while 5 consider it a Hold. The 12-month consensus target price for the stock is $35.57, which reflects an upside potential of 25.56% over the current price.

Institutional Ownership

Nine Chapters Capital Management Llc had the biggest stake with ownership of 12,500 shares as of q2 2015 for 3.06% of the stock exposure. Dean Capital Management is another notably bullish investment professional who is having 47,350 shares of Owens & Minor or 1.71% of their stock exposure. Further, Cwm Llc have 1.29% of their stock exposure invested in the company for 537,428 shares. The Norway-based fund Sector Gamma As revealed it had purchased so far a stake worth about 1.26% of the investment professional’s stock portfolio in Owens & Minor. The New York-based fund Adirondack Research & Management Inc. is also positive about the stock, possessing 211,172 shares or 1.24% of their stock exposure.

Owens & Minor (NYSE:OMI) Profile

Owens & Minor, Inc. is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Owens & Minor (NYSE:OMI) traded up 1.40% on 4 September, hitting $28.33. A total of shares of the company’s stock traded hands. This is down from average of 839,617 shares. Owens & Minor has a 52 week low of $26.91 and a 52 week high of $37.02. The company has a market cap of $1.73B and a P/E ratio of 18.03.

Get the latest Owens & Minor (NYSE:OMI) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Owens & Minor (NYSE:OMI) Rating was Increased by Professional Analysts at Robert W. Baird from Underperform to Neutral. The Target Price per Share is to $28.0 appeared first on Octafinance.



This post first appeared on Octafinance – Financial News, Reports And Intell, please read the originial post: here

Share the post

Owens & Minor (NYSE:OMI) Rating was Increased by Professional Analysts at Robert W. Baird from Underperform to Neutral. The Target Price per Share is to $28.0

×

Subscribe to Octafinance – Financial News, Reports And Intell

Get updates delivered right to your inbox!

Thank you for your subscription

×